184 related articles for article (PubMed ID: 9229194)
21. Effect of mazindol on body weight and insulin sensitivity in severely obese patients after a very-low-calorie diet therapy.
Nishikawa T; Iizuka T; Omura M; Kuramoto N; Miki T; Ito H; Chiba S
Endocr J; 1996 Dec; 43(6):671-7. PubMed ID: 9075607
[TBL] [Abstract][Full Text] [Related]
22. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects.
Wing RR; Marcus MD; Salata R; Epstein LH; Miaskiewicz S; Blair EH
Arch Intern Med; 1991 Jul; 151(7):1334-40. PubMed ID: 2064484
[TBL] [Abstract][Full Text] [Related]
23. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
[TBL] [Abstract][Full Text] [Related]
24. Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes.
Pascale RW; Wing RR; Butler BA; Mullen M; Bononi P
Diabetes Care; 1995 Sep; 18(9):1241-8. PubMed ID: 8612437
[TBL] [Abstract][Full Text] [Related]
25. Effect of NIDDM on the kinetics of whole-body protein metabolism.
Gougeon R; Pencharz PB; Marliss EB
Diabetes; 1994 Feb; 43(2):318-28. PubMed ID: 8288057
[TBL] [Abstract][Full Text] [Related]
26. Caloric restriction improves glycaemic control without reducing plasma branched-chain amino acids or keto-acids in obese men.
Sayda MH; Abdul Aziz MH; Gharahdaghi N; Wilkinson DJ; Greenhaff PL; Phillips BE; Smith K; Idris I; Atherton PJ
Sci Rep; 2022 Nov; 12(1):19273. PubMed ID: 36369511
[TBL] [Abstract][Full Text] [Related]
27. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
28. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
[TBL] [Abstract][Full Text] [Related]
29. Effects of VLCD in obese NIDDM (non-insulin dependent diabetes) on glucose, insulin and C-peptide dynamics.
Weck M; Hanefeld M; Schollberg K
Int J Obes; 1989; 13 Suppl 2():159-60. PubMed ID: 2693380
[No Abstract] [Full Text] [Related]
30. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.
Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K
Diabetes Care; 1995 Jun; 18(6):775-8. PubMed ID: 7555502
[TBL] [Abstract][Full Text] [Related]
31. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus.
Hughes TA; Gwynne JT; Switzer BR; Herbst C; White G
Am J Med; 1984 Jul; 77(1):7-17. PubMed ID: 6377892
[TBL] [Abstract][Full Text] [Related]
32. Quality of life in type 2 diabetes mellitus after a very low calorie diet and exercise.
Snel M; Sleddering MA; Vd Peijl ID; Romijn JA; Pijl H; Meinders AE; Jazet IM
Eur J Intern Med; 2012 Mar; 23(2):143-9. PubMed ID: 22284244
[TBL] [Abstract][Full Text] [Related]
33. Glucose and insulin responses in isolated human lymphocytes reflect in vivo status: effects of VLCD treatment.
Tu KY; Matthews R; Topek NH; Matthews KS
Biochem Biophys Res Commun; 1994 Jul; 202(2):1169-75. PubMed ID: 8048930
[TBL] [Abstract][Full Text] [Related]
34. Improved glucose metabolism after gastric bypass: evolution of the paradigm.
Pournaras DJ; Nygren J; Hagström-Toft E; Arner P; le Roux CW; Thorell A
Surg Obes Relat Dis; 2016; 12(8):1457-1465. PubMed ID: 27387696
[TBL] [Abstract][Full Text] [Related]
35. Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes.
Paisey RB; Frost J; Harvey P; Paisey A; Bower L; Paisey RM; Taylor P; Belka I
J Hum Nutr Diet; 2002 Apr; 15(2):121-7. PubMed ID: 11972741
[TBL] [Abstract][Full Text] [Related]
36. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
[TBL] [Abstract][Full Text] [Related]
37. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.
Boden G; Sargrad K; Homko C; Mozzoli M; Stein TP
Ann Intern Med; 2005 Mar; 142(6):403-11. PubMed ID: 15767618
[TBL] [Abstract][Full Text] [Related]
38. Effects of intermittent very-low calorie diet on glycemic control and cardiovascular risk factors in obese patients with type 2 diabetes mellitus: A randomized controlled trial.
Umphonsathien M; Rattanasian P; Lokattachariya S; Suansawang W; Boonyasuppayakorn K; Khovidhunkit W
J Diabetes Investig; 2022 Jan; 13(1):156-166. PubMed ID: 34176234
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
Gumbiner B; Van Cauter E; Beltz WF; Ditzler TM; Griver K; Polonsky KS; Henry RR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2061-8. PubMed ID: 8964829
[TBL] [Abstract][Full Text] [Related]
40. Impact of associated conditions on glycemic control of NIDDM patients.
Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
